                         LISTAGEM DE SEQUNCIAS

<110>  Instituto Butantan
 
<120>  COMPOSTO PARA A MODULAO DE VIAS DE RLR, TLR, OAS E/OU 
       ONCOSTATINA M, USO DO MESMO PARA A PREPARAO DE UM 
       MEDICAMENTO, COMPOSIO, MTODO PARA MODULAO DAS DITAS 
       VIAS E MTODO DE TRATAMENTO

<130>  000000000000

<150>  BR 102018074043-1
<151>  22/11/2018

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  129
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Amblyomin-X

<400>  1

Met Arg Gln Leu Ala Val Leu Ala Leu Val Ile Phe Thr Gly Met Cys 
1               5                   10                  15      


Val Glu Ser Gln Ser Ala Asn Ser Lys Ala Val Cys Asn Leu Pro Lys 
            20                  25                  30          


Leu Ala Gly Asp Glu Thr Cys Ser Asn Lys Thr Glu Ile Arg Trp Tyr 
        35                  40                  45              


Tyr Asn Gly Thr Ala Cys Glu Ala Phe Ile Phe Lys Gly Cys Gly Gly 
    50                  55                  60                  


Asn Asp Asn Asn Phe Asp Arg Val Asp Asp Cys Gln Arg Leu Cys Glu 
65                  70                  75                  80  


Glu Gln Thr His Phe His Phe Glu Ser Pro Lys Leu Ile Cys Phe Lys 
                85                  90                  95      


Val Gln Asp Tyr Trp Ile Leu Asn Asp Ile Met Lys Lys Asn Leu Thr 
            100                 105                 110         


Gly Ile Ser Leu Lys Ser Glu Glu Glu Asp Ala Asp Ser Gly Glu Ile 
        115                 120                 125             


Asp 


<210>  2
<211>  11
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptideo sinttico

<400>  2

Val Cys Asn Leu Pro Lys Leu Ala Gly Asp Glu 
1               5                   10      


<210>  3
<211>  11
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  3

Gly Asp Glu Thr Cys Ser Asn Lys Thr Glu Ile 
1               5                   10      


<210>  4
<211>  14
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  4

Ile Arg Trp Tyr Tyr Asn Gly Thr Ala Cys Glu Ala Phe Ile 
1               5                   10                  


<210>  5
<211>  11
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  5

Lys Gly Cys Gly Gly Asn Asp Asn Asn Phe Asp 
1               5                   10      


<210>  6
<211>  13
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  6

Asn Asn Phe Asp Arg Val Asp Asp Cys Gln Arg Leu Cys 
1               5                   10              


<210>  7
<211>  13
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  7

Asn Asn Phe Asp Arg Val Asp Asp Ser Gln Arg Leu Cys 
1               5                   10              


<210>  8
<211>  27
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  8

Val Cys Asn Leu Pro Lys Leu Ala Gly Asp Glu Thr Cys Ser Asn Lys 
1               5                   10                  15      


Thr Glu Ile Arg Trp Tyr Tyr Asn Gly Thr Ala 
            20                  25          


<210>  9
<211>  29
<212>  PRT
<213>  Sequncia Artificial

<220>
<223>  Peptdeo sinttico

<400>  9

Gly Thr Ala Cys Glu Ala Phe Ile Phe Lys Gly Cys Gly Gly Asn Asp 
1               5                   10                  15      


Asn Asn Phe Asp Arg Val Asp Asp Cys Gln Arg Leu Cys 
            20                  25                  


